CorMedix (CRMD) EBIT Margin (2013 - 2025)

CorMedix's (CRMD) quarterly EBIT Margin came in at 46.27% in Q4 2025, down 14635.0% year-on-year from N/an in Q4 2024, and down 193.97% quarter-over-quarter from 49.24% in Q3 2025.

CorMedix (CRMD) EBIT Margin (2013 - 2025) Analysis & Trends

CorMedix has disclosed EBIT Margin across 12 years of filings, most recently posting 46.27% for Q4 2025.

  • EBIT Margin for Q4 2025 came in at 46.27%, down 14635.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 10.11% (up 1943.0% YoY), and the FY2025 annual result was 10.11%, up 1944.0% from the prior year.
  • EBIT Margin came in at 46.27% for Q4 2025 at CorMedix, down from 49.24% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 100.08% in Q4 2024 to a low of 102126.07% in Q3 2022.
  • The 4-year median for EBIT Margin is 8169.54% (2021), against an average of 25281.78%.
  • Peak annual rise in EBIT Margin reached 3304022 bps in 2022, while the deepest fall reached 8392529 bps in 2022.
  • CorMedix's EBIT Margin stood at 13794.92% in 2021, then plunged by 105 bps to 28244.66% in 2022, then jumped by 100 bps to 100.08% in 2024, then tumbled by 146 bps to 46.27% in 2025.
  • The last three EBIT Margin figures came in at 46.27% (Q4 2025), 49.24% (Q3 2025), and 49.18% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn -6.43%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 38.10%
9 Abivax 91.71 Bn 91.71 Bn - -
10 CorMedix 631,378.03 -154.57 Mn 107.31 Mn -46.27%

Historic Data

Download Data
DateValue
Dec 31, 2025 -46.27%
Sep 30, 2025 49.24%
Jun 30, 2025 49.18%
Mar 31, 2025 51.50%
Dec 31, 2024 100.08%
Sep 30, 2024 -28.70%
Jun 30, 2024 -1,898.09%
Dec 31, 2022 -28,244.66%
Sep 30, 2022 -102,126.07%
Jun 30, 2022 -38,773.09%
Mar 31, 2022 -92,094.83%
Dec 31, 2021 -13,794.92%
Sep 30, 2021 -22,487.18%
Jun 30, 2021 -71,813.31%
Mar 31, 2021 -8,169.54%
Dec 31, 2020 -10,921.20%
Sep 30, 2020 -7,099.29%
Jun 30, 2020 -54,251.71%
Mar 31, 2020 -7,577.91%
Dec 31, 2019 -21,695.96%